VANCOUVER, British Columbia, March 20 /PRNewswire-FirstCall/ -- The following was issued today by Robert Kramer, Director, Current Technology Corporation :
Current Technology reports the signing of an exclusive distributorship agreement for the Republic of Turkey with Sanomed Medikal Teknoloji Co. (“Sanomed”). The agreement provides for the purchase of 34 ElectroTrichoGenesis (“ETG”) Mark 1 devices over the next 4 years. The principal of Sanomed, Mr. Ali Bicken, and his associate, Dr. Serafettin Saracoglu, received training in Vancouver in February and two ETGs were delivered last week to dermatology/aesthetic clinics in Istanbul.
Mr. Bicken owns and operates 3 Dermacare Clinics in Istanbul providing, amongst other services, hair removal, vascular and pigmented lesion therapies, acne treatments and skin rejuvenation. Sanomed was founded by Mr. Bicken to provide lasers and other aesthetic equipment to clinics and medi-spas, after he recognized many such products purchased by his Dermacare Clinics were not properly represented in Turkey.
The combination of Dermacare Clinics and Sanomed, a full service company employing biomedical engineers, technicians and sales and support staff, provides Mr. Bicken with an existing customer base to target for ETG sales. The marketing and sales effort will be kicked off later this month at a major dermatology and cosmetic exhibition in Istanbul where ETG will be introduced. Mr. Bicken has expressed confidence that his sales targets will be easily exceeded.
“We are impressed with Mr. Bicken’s acumen and enthusiasm,” states Current Technology’s COO Anthony Harrison. “He has a solid grounding in the aesthetics field and ETG is a natural fit for his existing customer base.”
“Mr. Bicken is aware of our activities with Current Technology (UK) Ltd. and recognizes his contract will be assigned to our subsidiary at the appropriate time,” states CEO Robert Kramer.
ABOUT CURRENT TECHNOLOGY CORPORATION
Current Technology Corporation remains committed to developing its non- invasive pulsed electro-stimulation technology. This technology has enabled the company to develop two separate and distinct products emanating from the TrichoGenesis platform, thus far, that offer help for those concerned with their hair: ElectroTrichoGenesis (ETG) and CosmeticTrichoGenesis (CTG). Current Technology holds patents throughout the world and has spent over US $15 million in research and development of its TrichoGenesis platform and systems. The patents encompass the technology, methodology and design of the Company’s products.
Current Technology Corporation
CONTACT: Corporate: Robert Kramer of Current Technology Corporation,+1-800-661-4247 or +1-604-684-2727, rkramer@current-technology.com;Investor Relations: Richard Hannon of Polestar Communications, for CurrentTechnology Communications, 1-866-858-4100
Web site: http://www.current-technology.com/
